logo image
search icon
Global Implantable Infusion Pumps Market

Implantable Infusion Pumps Market Size, Share & Trends Analysis Report By Product Type (Piston Type Infusion Pumps, Creeping Type Infusion Pumps, Enteral Pump, Elastomeric Pump, Insulin Pump, Syringe Pump), Application, By End-User Region And Segment Forecasts, 2024-2031

Report ID : 1145 | Published : 2024-10-18 | Pages: 190 | Format:

The Implantable Infusion Pumps Market Size is valued at USD16.24 Billion in 2023 and is predicted to reach USD 23.96 Billion by the year 2031 at a 5.15 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The improvements in medical device technology and favorable high-tech medical treatments are expanding the market's future growth.
  • As healthcare spending and investments in healthcare infrastructure continue to rise, implantable infusion pumps are becoming more popular.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • High treatment costs and a lack of knowledge might slow this industry's growth.

 implantable infusion pumps

The global implantable infusion pumps market is segmented on the basis of application and region. Based on the application, the market is divided into malignant pain management, cancer treatment, non-malignant pain management, and spasticity treatment. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.

Recent Developments:

In Nov 2022, Medtronic introduced the first and only infusion set for insulin pumps in the world, which has increased wear duration by seven days in the United States. Typically, an insulin pump supplied insulin to the body via tubing known as the infusion set, which required replacement every two to three days

Competitive Landscape

Some of The Key Players in The Implantable Infusion Pumps Market:

  • Codman & Shurtleff, Inc (Johnson & Johnson)
  • I-Flow Corp/Hylard Health
  • Flowobix Medical, Inc.
  • Medtronic
  • Tricumed Medizintechnik GmbH.
  • Debiotech SA
  • Eksigent Technologies LLC
  • InBrain Pharma SAS
  • Intarcia Therapeutics Inc
  • Other Prominent Players

The Implantable Infusion Pumps Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 16.24 Billion

Revenue Forecast In 2031

USD 23.96 Billion

Growth Rate CAGR

CAGR of 5.15 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion, Volume (Unit), and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Application, By Product Type, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Codman & Shurtleff, Inc (Johnson & Johnson), I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., Debiotech SA, Eksigent Technologies LLC, InBrain Pharma SAS, Intarcia Therapeutics Inc., and others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Implantable Infusion Pumps Market Snapshot

Chapter 4. Global Implantable Infusion Pumps Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:

5.2.1. Piston Type Infusion Pumps
5.2.2. Creeping Type Infusion Pumps
5.2.3. Enteral Pump
5.2.4. Elastomeric Pump
5.2.5. Insulin Pump
5.2.6. Syringe Pump

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

6.2.1. Cancer Treatment
6.2.2. Pediatrics/Neonatology
6.2.3. Gastroenterology
6.2.4. Hematology
6.2.5. Diabetes
6.2.6. Spasticity treatment
6.2.7. Others

Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:

7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Specialty Clinics

Chapter 8. Implantable Infusion Pumps Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.2. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.1.3. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.1.4. North America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.1.4.1. U.S.
8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.2.2. Europe Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.2.3. Europe Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.2.4. Europe Implantable Infusion Pumps Market revenue (US$ Million) by country, 2024-2031
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.3.2. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.3.3. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.3.4. Asia Pacific Implantable Infusion Pumps Market revenue (US$ Million) by country, 2024-2031
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific


8.4. Latin America

8.4.1. Latin America Implantable Infusion Pumps Market revenue (US$ Million) By Application, 2024-2031
8.4.2. Latin America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.4.3. Latin America Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.4.4. Latin America Implantable Infusion Pumps Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America

8.5. Middle East & Africa
8.5.1. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.5.3. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) estimates and forecasts By End-User, 2024-2031
8.5.4. Middle East & Africa Implantable Infusion Pumps Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA

Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. Codman & Shurtleff, Inc (Johnson & Johnson)
9.2.2. I-Flow Corp/Hylard Health
9.2.3. Flowobix Medical, Inc.
9.2.4. Medtronic
9.2.5. Tricumed Medizintechnik GmbH.
9.2.6. Debiotech SA
9.2.7. Eksigent Technologies LLC
9.2.8. InBrain Pharma SAS
9.2.9. Intarcia Therapeutics Inc
9.2.10. Other Prominent Players

Global Implantable Infusion Pumps Market Segmentation:

Global Implantable Infusion Pumps Market by Product Type

  • Piston Type Infusion Pumps
  • Creeping Type Infusion Pumps
  • Enteral Pump
  • Elastomeric Pump
  • Insulin Pump
  • Syringe Pump

implantable infusion pumps

Global Implantable Infusion Pumps Market by Application

  • Cancer Treatment
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Spasticity treatment
  • Others

Global Implantable Infusion Pumps Market by End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Global Implantable Infusion Pumps Market Based on Region

Europe Implantable Infusion Pumps Market Outlook  by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Implantable Infusion Pumps Market Outlook  by Country

  • U.S.
  • Canada

Asia Pacific Implantable Infusion Pumps Market Outlook  by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Implantable Infusion Pumps Market Outlook  by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Implantable Infusion Pumps Market Outlook by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Implantable Infusion Pumps Market Size?

The Implantable Infusion Pumps Market is expected to grow at a 5.15% CAGR during the forecast period for 2024-2031.

Codman & Shurtleff, Inc (Johnson & Johnson), I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., Debiotech SA

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4182
$10000
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach